Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2011
Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancerMotofumi Tanaka, Ping Chang, Yanan Li, et al.
European Journal of Radiology|February 13, 2017
Early clinical esophageal adenocarcinoma (cT1): Utility of CT in regional nodal metastasis detection and can the clinical accuracy be improved?Sonia L Betancourt Cuellar, Bradley Sabloff, Brett W Carter, et al.
Cancer Research|March 29, 2013
Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinomaShumei Song, Dipen M Maru, Jaffer A Ajani, et al.
Annals of Surgical Oncology|September 18, 2014
RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastasesGiuseppe Zimmitti, Junichi Shindoh, Yoshihiro Mise, et al.
The American Journal of Surgical Pathology|August 11, 2010
Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastasesDipen M Maru, Scott Kopetz, Piyaporn Boonsirikamchai, et al.
Annals of Surgical Oncology|March 27, 2016
RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver MetastasesKristoffer Watten Brudvik, Yoshihiro Mise, Michael Hsiang Chung, et al.
Journal of the Mechanical Behavior of Biomedical Materials|May 31, 2015
The High performance of nanocrystalline CVD diamond coated hip joints in wear simulator testM M Maru, M Amaral, S P Rodrigues, et al.
The Annals of Thoracic Surgery|July 20, 2014
Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiationViren R Patel, Wayne L Hofstetter, Arlene M Correa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2012
Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastasesJunichi Shindoh, Evelyne M Loyer, Scott Kopetz, et al.
Pageof 17